Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
17 participants
INTERVENTIONAL
2008-12-31
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Laser Therapy for Treating Hypertrophic Burn Scars in Children
NCT01653691
The Role of Pulsed Dye Laser Therapy in the Management of Burn Scars
NCT01488240
Treatment of Surgical Scars With Fractional Photothemolysis Versus Pulse Dye Laser
NCT00685243
CO2 Laser Revision for Burn Related Donor Site Scars
NCT04456127
Treatment of Surgical Scars Using the Pulsed Dye Laser
NCT00970671
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this study we will treat the seams of 1/2 of a skin graft with a pulsed-dyed laser, beginning about one month after surgery. We will use objective measures of color (redness on digital pictures), scar volume(via laser scanning), and elasticity(measured by BTC-2000) as well as subjective assessment by an independent observer and the patient.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Treatment of 1/2 of skin graft with pulsed-dye laser
Pulsed-dye laser will be applied to 1/2 of the seam of the skin graft, using a 10mm spot size, and sufficient pulse-width and fluency to induce purpura.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* not pregnant
* new skin graft to extremity
* able to follow simple instructions
Exclusion Criteria
* pregnancy
* any behavior pattern that would lead to conclusion that patient may not reliably follow simple instructions
9 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shriners Hospitals for Children
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
John Kevin Bailey
J. Kevin Bailey, MD Staff Surgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John K Bailey, MD
Role: PRINCIPAL_INVESTIGATOR
Shriners Hosptials for Children
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shriners Hospitals for Children, Cincinnati
Cincinnati, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08-6-24-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.